Baxter International (BAX) Capital Expenditures (2009 - 2026)

Baxter International (BAX) has reported Capital Expenditures for 18 consecutive years, with $116.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Capital Expenditures fell 17.14% year-over-year to $116.0 million in Q2 2026; TTM through Jun 2026 was $504.0 million, a 4.55% decrease from a year earlier, with the FY2025 full-year figure at $513.0 million, up 15.02% from the prior year.
• Capital Expenditures was $116.0 million for Q2 2026 at Baxter International, down from $137.0 million in the prior quarter.
• Over five years, Capital Expenditures peaked at $165.0 million in Q1 2023 and troughed at -$61.0 million in Q4 2022.
• A 5-year average of $112.3 million and a median of $133.0 million in 2024 frame the typical range for Capital Expenditures.
• Across the five-year window, Capital Expenditures tumbled 133.33% in 2022 and surged 1016.67% in 2024, its largest moves.
• Over 5 years, Capital Expenditures stood at -$61.0 million in 2022, then surged by 250.82% to $92.0 million in 2023, then jumped by 43.48% to $132.0 million in 2024, then gained by 6.06% to $140.0 million in 2025, then decreased by 17.14% to $116.0 million in 2026.
• The last three Capital Expenditures figures came in at $116.0 million (Q2 2026), $137.0 million (Q1 2026), and $140.0 million (Q4 2025), per Business Quant data.